Alzheimer’s is already one of the costliest chronic diseases to the country–$214 billion in 2014 alone. And it’s only become worse, as Alzheimer’s and other dementias are becoming more and more prevalent among the aging U.S. population. Meanwhile, research into treating the disease has been dramatically underfunded historically, and we have no –Â zero — effective disease-modifying drugs for Alzheimer’s. Despite some recent investments, funding remains a fraction of the $2 billion that the NAPA Advisory Council recommended. It’s one of the the most devastating diseases we face, and no one wants to talk about it.
